Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

95153-31-4

Perindoprilat

95153-31-4
4562-27-0

4(3H)-Pyrimidinone

4562-27-0
51940-44-4

Pipemidic acid

51940-44-4
623-39-2

3-Methoxy-1,2-propanediol

623-39-2
61-25-6

Papaverine HCl

61-25-6
60145-22-4

PCB 154

60145-22-4
14255-87-9

Parbendazole

14255-87-9
552-59-0

Prunetin

552-59-0
3681-99-0

Puerarin

3681-99-0
171228-49-2

Posaconazole

171228-49-2
149676-40-4

Pefloxacin mesylate 2H2O

149676-40-4
36322-90-4

Piroxicam

36322-90-4
1786-81-8

Prilocaine HCl

1786-81-8
92-82-0

Phenazine

92-82-0
68685-55-2

rac-Parconazole Oxalate

68685-55-2
2078-54-8

Propofol

2078-54-8
57-41-0

Phenytoin

57-41-0
66-97-7

Psoralen

66-97-7
29868-97-1

Pirenzepine 2HCl

29868-97-1
55268-74-1

Praziquantel

55268-74-1